The best days of Cipher ($CPH.TO) are still ahead

After this game-changing acquisition, I see another 200% upside

If you are active on FinTwit, you are probably familiar with Cipher and/or Moberg, both of whom have been darlings on FinTwit. But while most FinTwit darlings may turn out badly (see Leatt), I think Cipher's best days are yet to come. Despite its run since 2020. In fact, I just bought more shares now, for the first time since my original purchase in 2023 at CAD 3.55.

But let us start at the beginning. If you are familiar with Cipher, you can skip this part and go straight to part two, where I will paint a picture of what I think Cipher might look like in the future. I won't go into great detail about MOB-15 and the drug itself, but will focus on what changes the recent acquisition will bring to Cipher.